6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
10m ago	Samsung Biologics Reports First Quarter 2026 Financial Results
36m ago	EQT AB (publ) Q1 Announcement 2026
36m ago	2026 ASCO Preview \| Results from Phase III Study of Anbenitamab (KN026) Combined with HB1801 in Neoadjuvant Treatment for Breast Cancer Selected for LBA Oral Presentation
36m ago	Q1 2026 Production Report
37m ago	Broadridge Launches Central Risk and Liquidity Optimization Solution to Unify Trade Execution, Liquidity and Risk Management

About

Wuxi Biologics (HK:2269) — investor relations, events, news, and company updates on 6ix.

Latest News

WuXi Biologics Recognized by Morningstar Sustainalytics as Industry and Regional ESG Leader for Sixth Year

WuXi Biologics Achieves ISO 13485 Certification, Signifying Strong Capabilities in Drug-Device Combination Product Development and Manufacturing

WuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year

WuXi Biologics Reports Record 2025 Annual Results, Operational Excellence Driven by Digital-Native Architecture

WuXi Biologics Reports Record 2025 Annual Results

Recent Videos

WuXi Biologics | Building Scale and Expertise in Ireland

WuXi Biologics | Building Scale and Expertise in Ireland

Apr 14, 2026

Buy Wuxi Biologics Cayman Inc Stock Quick Guide (02269.HK)

Buy Wuxi Biologics Cayman Inc Stock Quick Guide (02269.HK)

Apr 08, 2026

Cómo comprar acciones de Wuxi Biologics Cayman Inc (02269.HK)

Cómo comprar acciones de Wuxi Biologics Cayman Inc (02269.HK)

Apr 04, 2026

Inside the US Drug Product Development and Manufacturing

Inside the US Drug Product Development and Manufacturing

Mar 31, 2026

Community Chat

Ask AI